×
Bausch Health Cos Receivables 2010-2024 | BHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bausch Health Cos receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Bausch Health Cos Receivables 2010-2024 | BHC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bausch Health Cos receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$24.9B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$6.8B
Supernus Pharmaceuticals (SUPN)
$2.1B
Amphastar Pharmaceuticals (AMPH)
$1.7B
Personalis (PSNL)
$396M
Taysha Gene Therapies (TSHA)
$314M
Assembly Biosciences (ASMB)
$95M
Sol-Gel Technologies (SLGL)
$25M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M